
1.66MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US09073Q3039
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
0.18
PEG Ratio
-
Book Value
1.74
Dividend Share
-
Dividend Yield
-
Earnings Share
17.52
Wall Street Target Price
700.00
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
1,214,000
Gross Profit TTM
-3,998,000
EBITDA
-6,918,000
Profit Margin
-261.37%
Return On Assets TTM
-35.85%
Return On Equity TTM
-29.19%
Revenue Per Share TTM
4.337
Qtly Revenue Growth YOY
-16.60%
Diluted Eps TTM
17.52
Qtly Earnings Growth YOY
87.20%
Trailing PE
0.18
Forward PE
0
Price Sales TTM
1.3711
Price Book MRQ
0.256
Enterprise Value Revenue
6
Enterprise Value EBITDA
1
158.16
13.87%267.34
1.62%552.84
0.91%832.98
0.51%1015.48
0.37%995.00
0.00%120.00
0.00%128.50
-0.56%30.10
-0.53%210.42
-0.52%